Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McIver Zachariah
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Winter Charles M.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Robinson Byron
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DiRaimondo Thomas
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dobek Maria
Janux Therapeutics | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Officer Winter Charles M.
Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer McIver Zachariah
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meyer Andrew Hollman
Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meyer Andrew Hollman
Janux Therapeutics | 8-K: Current report
Janux Therapeutics | 424B5: Prospectus
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 424B5: Prospectus
Janux Therapeutics | 8-K: Current report